+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Saphris"

From
Antipsychotic Drugs: Technologies and Global Markets - Product Thumbnail Image

Antipsychotic Drugs: Technologies and Global Markets

  • Report
  • September 2018
  • 174 Pages
  • Global
From
Schizophrenia Disease Coverage to 2024 - Product Thumbnail Image

Schizophrenia Disease Coverage to 2024

  • Report
  • July 2019
  • 498 Pages
  • Global
Drug Overview: Saphris - Product Thumbnail Image

Drug Overview: Saphris

  • Report
  • April 2018
  • 34 Pages
  • Global
From
  • 4 Results (Page 1 of 1)
Loading Indicator

Saphris is a medication used to treat mental disorders such as schizophrenia, bipolar disorder, and depression. It is a type of atypical antipsychotic drug, which works by blocking certain receptors in the brain to reduce symptoms of mental illness. Saphris is available in tablet form and is taken orally. It is usually taken once or twice daily, depending on the patient's condition. Saphris is manufactured by Merck & Co., Inc. and is available in the United States, Canada, and Europe. Other companies that produce similar medications include AstraZeneca, Eli Lilly, and Janssen Pharmaceuticals. These companies offer a variety of medications to treat mental disorders, including antipsychotics, antidepressants, and mood stabilizers. The Saphris market is highly competitive, with many companies offering similar medications. Companies such as Merck & Co., AstraZeneca, Eli Lilly, and Janssen Pharmaceuticals are all major players in the market. Other companies such as Teva Pharmaceuticals, Mylan, and Sun Pharmaceuticals also offer medications for mental disorders. Show Less Read more